Advisors Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.8M | Buy |
73,921
+601
| +0.8% | +$206K | 0.28% | 113 |
|
|
2026
Q1 | $25.8M | Buy |
73,320
+1,506
| +2% | +$537K | 0.3% | 108 |
|
|
2025
Q4 | $23.5M | Buy |
71,814
+953
| +1% | +$302K | 0.28% | 110 |
|
|
2025
Q3 | $20M | Buy |
70,861
+2,095
| +3% | +$608K | 0.25% | 117 |
|
|
2025
Q2 | $19.2M | Buy |
68,766
+4,326
| +7% | +$1.23M | 0.26% | 115 |
|
|
2025
Q1 | $20.1M | Buy |
64,440
+5,791
| +10% | +$1.71M | 0.31% | 103 |
|
|
2024
Q4 | $15.3M | Buy |
58,649
+3,427
| +6% | +$1.02M | 0.24% | 123 |
|
|
2024
Q3 | $17.8M | Buy |
55,222
+2,059
| +4% | +$674K | 0.29% | 107 |
|
|
2024
Q2 | $16.6M | Buy |
53,163
+1,587
| +3% | +$466K | 0.29% | 104 |
|
|
2024
Q1 | $14.7M | Buy |
51,576
+47,267
| +1,097% | +$13.8M | 0.27% | 111 |
|
|
2023
Q4 | $1.24M | Buy |
+4,309
| New | +$1.17M | 0.03% | 275 |
|
|
2023
Q3 | – | Sell |
-2,585
| Closed | -$574K | – | 409 |
|
|
2023
Q2 | $574K | Sell |
2,585
-147
| -5% | -$34.1K | 0.01% | 299 |
|
|
2023
Q1 | $661K | Buy |
2,732
+534
| +24% | +$131K | 0.02% | 270 |
|
|
2022
Q4 | $578K | Sell |
2,198
-53
| -2% | -$14.2K | 0.02% | 288 |
|
|
2022
Q3 | $642K | Buy |
2,251
+87
| +4% | +$21.1K | 0.02% | 289 |
|
|
2022
Q2 | $527K | Sell |
2,164
-70
| -3% | -$17.2K | 0.02% | 293 |
|
|
2022
Q1 | $540K | Sell |
2,234
-303
| -12% | -$69.6K | 0.01% | 303 |
|
|
2021
Q4 | $571K | Sell |
2,537
-1,762
| -41% | -$372K | 0.02% | 306 |
|
|
2021
Q3 | $914K | Sell |
4,299
-43,340
| -91% | -$9.98M | 0.03% | 252 |
|
|
2021
Q2 | $11.6M | Sell |
47,639
-9,743
| -17% | -$2.4M | 0.37% | 89 |
|
|
2021
Q1 | $14.3M | Buy |
57,382
+4,635
| +9% | +$1.11M | 0.5% | 73 |
|
|
2020
Q4 | $12.1M | Buy |
52,747
+8,458
| +19% | +$1.95M | 0.46% | 74 |
|
|
2020
Q3 | $11.3M | Buy |
44,289
+11,743
| +36% | +$2.91M | 0.53% | 68 |
|
|
2020
Q2 | $7.68M | Buy |
32,546
+20,169
| +163% | +$4.6M | 0.38% | 82 |
|
|
2020
Q1 | $2.51M | Buy |
12,377
+1,950
| +19% | +$426K | 0.16% | 125 |
|
|
2019
Q4 | $2.51M | Buy |
10,427
+234
| +2% | +$51.6K | 0.12% | 166 |
|
|
2019
Q3 | $1.97M | Buy |
10,193
+1,413
| +16% | +$271K | 0.11% | 168 |
|
|
2019
Q2 | $1.62M | Buy |
8,780
+434
| +5% | +$77.7K | 0.1% | 168 |
|
|
2019
Q1 | $1.6M | Buy |
8,346
+194
| +2% | +$37K | 0.1% | 170 |
|
|
2018
Q4 | $1.59M | Buy |
8,152
+3,214
| +65% | +$627K | 0.12% | 163 |
|
|
2018
Q3 | $1.02M | Buy |
4,938
+201
| +4% | +$39.6K | 0.07% | 172 |
|
|
2018
Q2 | $874K | Buy |
4,737
+261
| +6% | +$46.2K | 0.06% | 174 |
|
|
2018
Q1 | $763K | Buy |
+4,476
| New | +$822K | 0.06% | 161 |
|
|
2017
Q4 | – | Sell |
-3,968
| Closed | -$740K | – | 192 |
|
|
2017
Q3 | $740K | Buy |
+3,968
| New | +$703K | 0.06% | 158 |
|
Other funds holding AMGN
Advisors Capital Management's AMGN Position: Q2 2026 in Review
Advisors Capital Management increased its Amgen (AMGN) stake by 0.82% in Q2 2026, buying an estimated $206K and bringing the position to 73,921 shares worth $26.8M. The position accounts for 0.28% of the portfolio, ranked #113.
Advisors Capital Management first reported a position in AMGN in Q3 2017 and has held it in 34 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Advisors Capital Management held 73,921 shares of Amgen worth $26.8M as of Q2 2026.
- Advisors Capital Management bought 601 Amgen shares in Q2 2026, an estimated $206K.
- Amgen made up 0.28% of Advisors Capital Management's portfolio in Q2 2026, its #113 holding.
- Advisors Capital Management first reported a position in Amgen in Q3 2017 and has held it in 34 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.